Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 4,490 shares at $66.45 ($299K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($299k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.45 | 890 | $59K | 19.8% |
| 2 | $66.45 | 890 | $59K | 19.8% |
| 3 | $66.52 | 984 | $65K | 21.9% |
| 4 | $66.52 | 984 | $65K | 21.9% |
| 5 | $67.24 | 415 | $28K | 9.3% |
| 6 | $67.27 | 324 |
| $22K |
| 7.3% |
| 7 | $68.10 | 3 | $204 | 0.1% |
| Total | $66.61 avg | 4,490 | $299K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |